KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synchronoss Technologies (SNCR) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Synchronoss Technologies (SNCR) over the last 6 years, with Q2 2025 value amounting to $627000.0.

  • Synchronoss Technologies' Asset Writedowns and Impairment changed N/A to $627000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $883000.0, marking a year-over-year decrease of 5110.74%. This contributed to the annual value of $2.5 million for FY2024, which is 3211.68% up from last year.
  • Per Synchronoss Technologies' latest filing, its Asset Writedowns and Impairment stood at $627000.0 for Q2 2025.
  • Synchronoss Technologies' 5-year Asset Writedowns and Impairment high stood at $2.1 million for Q2 2023, and its period low was -$441000.0 during Q4 2021.
  • For the 5-year period, Synchronoss Technologies' Asset Writedowns and Impairment averaged around $360750.0, with its median value being $407000.0 (2022).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 14123.08% in 2022, then surged by 87537.31% in 2023.
  • Synchronoss Technologies' Asset Writedowns and Impairment (Quarter) stood at -$441000.0 in 2021, then soared by 39.23% to -$268000.0 in 2022, then skyrocketed by 41.42% to -$157000.0 in 2023, then soared by 336.31% to $371000.0 in 2024, then skyrocketed by 69.0% to $627000.0 in 2025.
  • Its last three reported values are $627000.0 in Q2 2025, $371000.0 for Q4 2024, and -$115000.0 during Q3 2024.